NCT07692230Active, not recruiting
MRI-Driven Precision Typing and Response Prediction in Luminal Breast Cancer
MRI-driven Multiomics Research on Precise Typing and Response Prediction of Luminal Breast Cancer
Source: ClinicalTrials.gov · Last updated 21 Jul 2026
Brief summary (registry, in English)
Luminal breast cancer is characterized by marked heterogeneity, resulting in diverse treatment responses and long-term outcomes. This project aims to integrate MRI and multiomics data to achieve non-invasive molecular typing and precise response prediction. By linking imaging phenotypes with underlying molecular and pathological characteristics, the investigators will develop predictive models for treatment resistance, recurrence, and metastasis, ultimately supporting personalized treatment strategies and precision oncology.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 2000 (estimated)
- First submitted
- 26 Jun 2026
- Start date
- Jan 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Fudan University
- Diseases
- Childhood cancers
- NCT number
- NCT07692230
What you commit to
- Study type: Observational
- Planned participants: 2000
- From Jan 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pathological biopsy performed prior to the baseline MRI examination;
- Patients have received any form of prior treatment for the breast cancer;
Other illness
- History of other malignancies;
Other
- Incomplete or poor-quality MRI and/or pathological images;
- Missing clinical data.
Who the study is looking for
- Histopathologically confirmed invasive luminal breast cancer (HR+/HER2-);
- Patients who underwent breast MRI examination.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.